Report Detail
Global (United States, European Union and China) Cancer Molecular Biomarkers Market Research Report 2019-2025
- RnM3579934 |
- 08 July, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Other
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body.A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments.
Factors such as technological advancements, increasing research and development activities, increase in funding from various government and non-government organizations, rise in healthcare expenditure, non invasive technology, increasing incidences of cancer, and streamlined drug delivery process are expected to drive the market for cancer molecular biomarkers .In addition, growing survival rates and increased accuracy of diagnosis with the help of biomarkers are expected to drive market for cancer molecular biomarkers.
In 2019, the market size of Cancer Molecular Biomarkers is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Cancer Molecular Biomarkers.
This report studies the global market size of Cancer Molecular Biomarkers, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Cancer Molecular Biomarkers production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Correlogic Systems
AgendiaBv
BioMerieux
Aureon Laboratories
Astellas Pharma US
Becton
Diadexus
Abbott Laboratories
Affymetrix
Clarient
Biomoda
Beckman Coulter
Dickinson
Market Segment by Product Type
Genetic Methods
Protein Methods
Imaging
Market Segment by Application
Pharmaceutical Companies
Medical Laboratory
Hospital
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Cancer Molecular Biomarkers status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Cancer Molecular Biomarkers manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Cancer Molecular Biomarkers are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Cancer Molecular Biomarkers Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Genetic Methods
- 1.3.3 Protein Methods
- 1.3.4 Imaging
- 1.4 Market Segment by Application
- 1.4.1 Global Cancer Molecular Biomarkers Market Share by Application (2019-2025)
- 1.4.2 Pharmaceutical Companies
- 1.4.3 Medical Laboratory
- 1.4.4 Hospital
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Cancer Molecular Biomarkers Production Value 2014-2025
- 2.1.2 Global Cancer Molecular Biomarkers Production 2014-2025
- 2.1.3 Global Cancer Molecular Biomarkers Capacity 2014-2025
- 2.1.4 Global Cancer Molecular Biomarkers Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Cancer Molecular Biomarkers Market Size CAGR of Key Regions
- 2.2.2 Global Cancer Molecular Biomarkers Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Cancer Molecular Biomarkers Capacity by Manufacturers
- 3.1.2 Global Cancer Molecular Biomarkers Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Cancer Molecular Biomarkers Revenue by Manufacturers (2014-2019)
- 3.2.2 Cancer Molecular Biomarkers Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Cancer Molecular Biomarkers Market Concentration Ratio (CR5 and HHI)
- 3.3 Cancer Molecular Biomarkers Price by Manufacturers
- 3.4 Key Manufacturers Cancer Molecular Biomarkers Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Cancer Molecular Biomarkers Market
- 3.6 Key Manufacturers Cancer Molecular Biomarkers Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Genetic Methods Production and Production Value (2014-2019)
- 4.1.2 Protein Methods Production and Production Value (2014-2019)
- 4.1.3 Imaging Production and Production Value (2014-2019)
- 4.2 Global Cancer Molecular Biomarkers Production Market Share by Type
- 4.3 Global Cancer Molecular Biomarkers Production Value Market Share by Type
- 4.4 Cancer Molecular Biomarkers Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Cancer Molecular Biomarkers Consumption by Application
6 Production by Regions
- 6.1 Global Cancer Molecular Biomarkers Production (History Data) by Regions 2014-2019
- 6.2 Global Cancer Molecular Biomarkers Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Cancer Molecular Biomarkers Production Growth Rate 2014-2019
- 6.3.2 United States Cancer Molecular Biomarkers Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Cancer Molecular Biomarkers Import & Export
- 6.4 European Union
- 6.4.1 European Union Cancer Molecular Biomarkers Production Growth Rate 2014-2019
- 6.4.2 European Union Cancer Molecular Biomarkers Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Cancer Molecular Biomarkers Import & Export
- 6.5 China
- 6.5.1 China Cancer Molecular Biomarkers Production Growth Rate 2014-2019
- 6.5.2 China Cancer Molecular Biomarkers Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Cancer Molecular Biomarkers Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Cancer Molecular Biomarkers Consumption by Regions
- 7.1 Global Cancer Molecular Biomarkers Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Cancer Molecular Biomarkers Consumption by Type
- 7.2.2 United States Cancer Molecular Biomarkers Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Cancer Molecular Biomarkers Consumption by Type
- 7.3.2 European Union Cancer Molecular Biomarkers Consumption by Application
- 7.4 China
- 7.4.1 China Cancer Molecular Biomarkers Consumption by Type
- 7.4.2 China Cancer Molecular Biomarkers Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Cancer Molecular Biomarkers Consumption by Type
- 7.5.2 Rest of World Cancer Molecular Biomarkers Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 Correlogic Systems
- 8.1.1 Correlogic Systems Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Cancer Molecular Biomarkers
- 8.1.4 Cancer Molecular Biomarkers Product Introduction
- 8.1.5 Correlogic Systems Recent Development
- 8.2 AgendiaBv
- 8.2.1 AgendiaBv Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Cancer Molecular Biomarkers
- 8.2.4 Cancer Molecular Biomarkers Product Introduction
- 8.2.5 AgendiaBv Recent Development
- 8.3 BioMerieux
- 8.3.1 BioMerieux Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Cancer Molecular Biomarkers
- 8.3.4 Cancer Molecular Biomarkers Product Introduction
- 8.3.5 BioMerieux Recent Development
- 8.4 Aureon Laboratories
- 8.4.1 Aureon Laboratories Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Cancer Molecular Biomarkers
- 8.4.4 Cancer Molecular Biomarkers Product Introduction
- 8.4.5 Aureon Laboratories Recent Development
- 8.5 Astellas Pharma US
- 8.5.1 Astellas Pharma US Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Cancer Molecular Biomarkers
- 8.5.4 Cancer Molecular Biomarkers Product Introduction
- 8.5.5 Astellas Pharma US Recent Development
- 8.6 Becton
- 8.6.1 Becton Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Cancer Molecular Biomarkers
- 8.6.4 Cancer Molecular Biomarkers Product Introduction
- 8.6.5 Becton Recent Development
- 8.7 Diadexus
- 8.7.1 Diadexus Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Cancer Molecular Biomarkers
- 8.7.4 Cancer Molecular Biomarkers Product Introduction
- 8.7.5 Diadexus Recent Development
- 8.8 Abbott Laboratories
- 8.8.1 Abbott Laboratories Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of Cancer Molecular Biomarkers
- 8.8.4 Cancer Molecular Biomarkers Product Introduction
- 8.8.5 Abbott Laboratories Recent Development
- 8.9 Affymetrix
- 8.9.1 Affymetrix Company Details
- 8.9.2 Company Description and Business Overview
- 8.9.3 Production and Revenue of Cancer Molecular Biomarkers
- 8.9.4 Cancer Molecular Biomarkers Product Introduction
- 8.9.5 Affymetrix Recent Development
- 8.10 Clarient
- 8.10.1 Clarient Company Details
- 8.10.2 Company Description and Business Overview
- 8.10.3 Production and Revenue of Cancer Molecular Biomarkers
- 8.10.4 Cancer Molecular Biomarkers Product Introduction
- 8.10.5 Clarient Recent Development
- 8.11 Biomoda
- 8.12 Beckman Coulter
- 8.13 Dickinson
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Cancer Molecular Biomarkers Capacity, Production Forecast 2019-2025
- 9.1.2 Global Cancer Molecular Biomarkers Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Cancer Molecular Biomarkers Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Cancer Molecular Biomarkers Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Cancer Molecular Biomarkers Production Forecast by Type
- 9.7.2 Global Cancer Molecular Biomarkers Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Cancer Molecular Biomarkers Sales Channels
- 10.2.2 Cancer Molecular Biomarkers Distributors
- 10.3 Cancer Molecular Biomarkers Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Cancer Molecular Biomarkers. Industry analysis & Market Report on Cancer Molecular Biomarkers is a syndicated market report, published as Global (United States, European Union and China) Cancer Molecular Biomarkers Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Cancer Molecular Biomarkers market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
